Pathstone Family Office’s Dextera Surgical Inc. DXTR Stock Holding History

Pathstone Family Office’s Portfolio DXTR Stock Details DXTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,646	Closed	-$2K	–	220
2017 Q3	$2K	Hold	5,646	–	–	﹤0.01%	163
2017 Q2	$2K	Hold	5,646	–	–	﹤0.01%	366
2017 Q1	$6K	Buy	+5,646	New	+$7.25K	﹤0.01%	320
2016 Q4	–	Sell	-5,646	Closed	-$11K	–	232
2016 Q3	$11K	Hold	5,646	–	–	0.01%	128
2016 Q2	$10K	Buy	+5,646	New	+$11.6K	0.01%	147

Other funds holding DXTR

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Pathstone Family Office's DXTR Position: Q4 2017 in Review

Pathstone Family Office sold out of Dextera Surgical Inc. (DXTR) in Q4 2017, closing a stake of 5,646 shares — an estimated $2K sold.

Pathstone Family Office first reported a position in DXTR in Q2 2016 and held it in 5 quarters. The position peaked at $11K in Q3 2016. 3 funds tracked by Wall St. Rank hold DXTR as of Q4 2017.

Pathstone Family Office reported no remaining Dextera Surgical Inc. position as of Q4 2017 after selling out during the quarter.
Pathstone Family Office sold 5,646 Dextera Surgical Inc. shares in Q4 2017, an estimated $2K.
Pathstone Family Office first reported a position in Dextera Surgical Inc. in Q2 2016 and held it in 5 quarters.
Pathstone Family Office's Dextera Surgical Inc. position peaked at $11K in Q3 2016.
3 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q4 2017.

Based on Pathstone Family Office's 13F filing for Q4 2017, filed 12 Feb 2018.